logo
logo
Sign in
kriti singh
Followers 0 Following 0
kriti singh 2021-08-31
img

The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269By application, the drug discovery segment accounted for the largest share of the cell-based assays market in 2019.Based on application, the cell-based assays market is categorized into drug discovery, basic research, and other applications.

The drug discovery application segment dominated the market in 2019.

The large share of the drug discovery segment can be attributed to increasing R investments, technological innovations in supportive processes, the introduction of new drugs, and the growing number of CROs providing drug discovery services.To know about the assumptions considered for the study, Request a Sample PagesBy end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the cell-based assays market in 2019.Based on end users, the cell death assays market is segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes.

Pharmaceutical & biotechnology companies dominated the market in 2019.

The large share of this segment can be attributed to the increase in R expenditure, the growing number of drug discovery projects, and the adoption of strategic approaches such as collaborations to develop drug candidates.North America accounted for the largest share of the cell death assays market in 2019.In 2019, North America accounted for the largest share of the cell death assays market, followed by Europe.

The large share of the North American regional segment can be attributed to the availability of government and private funding for life science research, the growing penetration of CROs, comprehensive drug development regulations, and the rapid adoption of advanced technologies in the region.Key Market PlayersDanaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), AAT Bioquest (US) are the prominent players operating in the cell-based assays market.Recent DevelopmentsIn 2020, Danaher Corporation (US) launched ImageXpress Micro-confocal High-content Imaging System.In 2020, Thermo Fisher Scientific (US) acquired Phitonex, Inc. (US).

collect
0
kriti singh 2021-08-24
img

The global life science instrumentation market size is projected to grow from an estimated USD 60.0 billion in 2020 to USD 79.9 billion by 2025, at a CAGR of 5.9% during the forecast period.Market growth is driven largely by factors, such as increasing expenditure on research & development by pharmaceutical & biotechnology companies, growing public & private funding for life science research, and rising incidence of target diseases & genetic disorders.

The emerging markets and increasing demand for analytical instruments are expected to present avenues of growth for market players.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38The research application segment was the largest contributor to the life science instrumentation market in 2019The research application segment accounted for the largest share of the life science instrumentation application market in 2019.

The large share of the research applications segment can be attributed to evolving global regulatory scenarios for research data publication in analytical instruments-based researches, an increasing number of research studies coupled with growing public-private funding in the field of genomic researches, and the ongoing trend of laboratory automation & integration of robotics.Next-generation sequencing (NGS) to register the highest growth over the forecast period among life science instrumentation technologiesThe Next-generation sequencing (NGS) segment is expected to register the highest growth over the forecast among the life science instrumentation technologies market over the forecast period.

The significant growth of this segment is attributed to the advantages offered by NGS technologies in DNA sequencing, which substantially provides more throughput and minimizes the need for fragment-cloning methods.

In addition, continuous technological advancements and the increasing availability of cheaper sequencing platformsRequest a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38Asia Pacific is expected to grow at the highest CAGR in the life science instrumentation market during the forecast periodThe Asia Pacific is one of the major revenue-generating regions in the life science instrumentation industry.

The strategic expansions by key market players in emerging Asian countries, the growing pharmaceutical industry in India & China, and conferences, exhibitions, & meetings on analytical instruments is driving growth in the region.Key Market PlayersAgilent Technologies (US), Becton, Dickinson, and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and Waters Corporation (US).To speak to our analyst for a discussion on the above findings, click Speak to Analyst

collect
0
kriti singh 2021-08-19
img

The research study involved four major activities in estimating the current size of the cell & gene therapy manufacturing services market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.

After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180609441Major Market Growth Drivers:Growth in this market is primarily driven by the high incidence of cancer and other target diseases, increasing investments in pharmaceutical R, investments in advanced technologies by CDMOs, and increasing partnerships & agreements between pharmaceutical companies and CDMOs.

However, the high operational costs associated with cell & gene therapy manufacturing is expected to restrain the growth of gene therapy manufacturing services market market to a certain extent.Revenue Growth Analysis:The global cell & gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7 billion in 2021, at a CAGR of 12.4% during the forecast period.Browse and in-depth TOC on "Cell Therapy Manufacturing Services Market"348 – Tables44 – Figures299 – PagesThe cell therapy segment dominated the gene therapy manufacturing services market in 2020.On the basis of type, the cell therapy manufacturing services market is broadly segmented into cell therapy and gene therapy.

In 2020, cell therapy accounted for the largest share of the cell & gene therapy manufacturing services market.

collect
0
kriti singh 2021-08-13
img

The research study involves four major activities in estimating the current size of the biofilms treatment market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.

After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57398610Major Market Growth Drivers:The rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries are the major factors driving the growth of Wound biofilm market.Revenue Growth Analysis:The biofilms treatment market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%.Browse and in-depth TOC on" Biofilms Treatment Market"109 – Tables33 – Figures150 – PagesTraumatic and surgical wounds segment accounted for the largest share of the biofilms treatment market in 2019.Based on the wound type, the biofilms treatment market is segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns and other open wounds.

The surgical and traumatic wounds segment accounted for the largest market share in 2019.

The large share of this segment can be attributed to the growing prevalence of diabetes and the increasing number of surgical procedures performed.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=57398610Gauzes and dressings segment to witness the highest growth rate during the forecast periodBased on product, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and lavage solutions; and grafts and matrices.

collect
0
kriti singh 2021-08-31
img

Growth in the fluoroscopy systems market is attributed to factors such as advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, and the growing prevalence of chronic diseases.

[187 Pages Report] The fluoroscopy equipment market is expected to grow from USD 5.9 billion in 2020 to USD 7.5 billion by 2025, at a CAGR of 4.8% during the forecast period.To know about the assumptions considered for the study, download the pdf brochure“By product, the mobile C-arms segment is expected to grow at the highest CAGR during the forecast period.”On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.

The mobile C-arms segment is projected to register the highest growth during the forecast period.

The rising prevalence of cardiovascular diseases and the increasing number of orthopedic surgeries are some of the major factors driving the growth of the mobile C-arms market.

C-arms are used for a wide range of applications, including surgeries for cardiovascular diseases, neurosurgeries, and surgeries for gastroenterology, orthopedics, traumatology, and urology disorders.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341“By application, cardiology accounted for the largest share of the diagnostic applications market in 2019”On the basis of diagnostic applications, the fluoroscopy equipment market is segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications.

Cardiology is the largest diagnostic application segment of the fluoroscopy equipment market.

collect
0
kriti singh 2021-08-24
img

[183 Pages Report] The global veterinary ultrasound market size is projected to reach USD 448 million by 2025 from USD 338 million in 2020, at a CAGR of 5.8%.Factors such as growth in the companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, technological advancements are driving the growth of this market during the forecast period.

However, high cost of instruments and procedures is restraining the growth of Animal Ultrasound Market to some extent.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10482074The 2D ultrasound segment dominates the veterinary ultrasound industry, by type of ultrasound scannersBased on the type of scanners, the 2D segment accounted for the largest share of the veterinary ultrasound market in 2019.

The large share of this segment can primarily be attributed to the widespread popularity of these type of scanners in disease diagnosis as well as in pregnancy detection.By product, the cart-based segment accounted for the largest share of the market in 2019Based on product, the Animal Ultrasound Market is segmented into cart-based and portable ultrasound scanners.

In 2019, the cart-based segment accounted for the largest portion of the market due to its ease of use and is extensively used in hospitals, clinics and diagnostic centers.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10482074North America will continue to dominate the Animal Ultrasound Market during the forecast periodThe Animal Ultrasound Market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the animal/veterinary ultrasound industry in 2019.

The growth of the North American market is attributed to the increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the growing number of veterinary practices.

collect
0
kriti singh 2021-08-18
img

The Animal Health Market is projected to reach a value of USD 22.1 billion by 2025 from USD 15.6 billion in 2020, at a CAGR of 7.2% during the forecast period.Factors such as the rapid rise in livestock population, increasing awareness about animal health, and rising frequency of animal disease outbreaks are expected to drive the growth of the APAC animal health market.However, restrictions on the use of parasiticides in food-producing animals, shift toward vegetarian diets, and the rising cost of storage of animal vaccines are expected to restrain the growth of this market.To know about the assumptions considered for the study, Request for Free Sample ReportAPAC animal health Market DynamicsDrivers:  Rising demand of animal-derived food products According to FAO, South Asia is one of the major regions for dairy production and accounted for 20–25% of the global milk production in 2019.

In this region, India was the largest producer and consumer of milk, followed by China and Pakistan.

In 2020, the consumption of meat in India was found to be over 3.9 million metric tons; by 2030, this is expected to increase to 145.7 million metric tons.Restraints: Shift towards vegetarian dietThere is a significant rise in the prevalence of obesity and other chronic disorders.

The prevalence of obesity has increased more than twofold since 1980.

According to a journal published by Development Asia in 2018, two of five adults in the Asia Pacific region are found to be overweight or obese, and it is considered to be home to the largest absolute number of obese people, about 1 billion.To know about the assumptions considered for the study, download the PDF brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485Opportunities: Lucrative growth opportunities in India an ChinaOver the last few years, companion animal ownership has experienced steady growth, especially in emerging markets such as China and India.

Rapid urbanization and growing disposable incomes are some of the key factors driving pet ownership in these countries.

collect
0
kriti singh 2021-08-12
img

[117 Pages Report] The global bone densitometers market is projected to reach USD 311 million by 2024 from USD 247 million in 2019, at a CAGR of 4.7%.The growth in the Peripheral Bone Densitometers Market is majorly driven by the increasing prevalence of osteoporosis and the rising geriatric population.

However, factors such as the high cost of bone densitometers and low awareness are expected to hinder the growth of this market.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15369222The osteoporosis & osteopenia diagnosis segment is expected to grow at the highest CAGROn the basis of application, the Bone Densitometers Market has been segmented into osteoporosis & osteopenia diagnosis, body composition measurement, rheumatoid arthritis diagnosis, cystic fibrosis diagnosis, and chronic kidney disease diagnosis.

The osteoporosis & osteopenia diagnosis segment is projected to grow at the highest CAGR during the forecast period.

This can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=15369222The hospitals & specialty clinics segment accounted for the largest share of the bone densitometers market in 2018Based on end user, the Peripheral Bone Densitometers Market is segmented into hospitals & specialty clinics, diagnostic & imaging centers, and other end users.

In 2018, hospitals & specialty clinics accounted for the largest share of the market, and this trend is expected to continue during the forecast period.

The majority of bone density scans are performed in hospitals owing to the higher preference of patients for hospital-based treatment monitoring for diseases such as cystic fibrosis, chronic kidney diseases, and osteoporosis.The Asia Pacific is expected to grow at the highest rate in the Peripheral Bone Densitometers Market in 2018The Peripheral Bone Densitome0ters Market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period.

collect
0
kriti singh 2021-08-30
img

The study involved four major activities to estimate the current market size for sports medicine.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.

Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegmentsDownload a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=751Major Market Growth Drivers: Growth in the Body Recovery Market is primarily driven by factors such the increasing incidences of sports injuries, continuous influx of new products & treatment modalities, developments in the field of regenerative medicine, rising demand for minimally invasive surgeries.Revenue Growth Analysis:The sports medicine market is expected to grow from USD 5.5 billion in 2020 to USD 7.2 billion by 2025, at a CAGR of 5.7% during the forecast period.

Browse and in-depth TOC on" Sports Medicine Market" 245 – Tables 38 – Figures 266 – Pages Body support & recovery products expected to grow at the highest rate during the forecast period On the basis of products, the Body Recovery Market is segmented into body reconstruction products (fracture & ligament repair products, arthroscopy devices, implants, prosthetics, orthobiologics), body support & recovery products (braces & support, physiotherapy equipment, and compression clothing), and accessories.

collect
0
kriti singh 2021-08-23
img

[146 Pages Report] The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.

Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294 Consumables accounted for the largest share of the Urinalysis Systems Marketin 2019 The urine analyser market, based on product type, is segmented into consumables and instruments.

The consumables segment dominated this market in 2019.

The urinalysis consumables market is segmented into pregnancy & fertility kits, dipsticks, reagents, and disposables.

These kits have witnessed wide adoption amongst end users across the globe owing to their cost-effectiveness and ease of use.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294Increasing use of urinalysis in disease screening in 2019 Based on application, the urine analysis market is segmented into disease screening and pregnancy and fertility.

collect
0
kriti singh 2021-08-18
img

The market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global microbial identification market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects.

The size of the Microbial identification services market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10702182Major Market Growth Drivers:Growth in Microbial Identification Market is largely driven by the rising incidence of infectious diseases and the increasing frequency of pandemics, technological advancements, increasing food safety concerns, and increasing government initiatives and funding to detect and control antimicrobial-resistant species.Revenue Growth Analysis:[220 Pages Report] The global microbial identification market size is estimated to be USD 3.2 billion in 2020 and projected to reach USD 5.7 billion by 2025, at a CAGR of 12.2%.Browse and in-depth TOC on" Microbial Identification Market"261 – Tables33 – Figures220 – PagesBy the consumables segment, the panels/ID cards & media segment accounted for the largest share of the microbial identification market in 2019.On the basis of product & service type, the consumables market is segmented into panels/ID cards & media, kits and other consumables.

In 2019, panels/ID cards & media accounted for the largest share of the consumables segment.

Panels, ID cards, and media enable the easy and rapid identification of microorganisms and is a key factors driving market growthRequest a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10702182By technology, the mass spectrometry segment accounted for the largest share of the microbial identification market in 2019.On the basis of technology, the Microbial identification services market is categorized into five technology segments— mass spectrometry, PCR, flow cytometry, microscopy, and other microbial identification technologies.

The mass spectrometry segment accounted for the largest share in 2019, due to its high speed, high specificity, and applicability for a wide range of microorganisms such as bacteria, archaea, and fungi.

collect
0
kriti singh 2021-08-11
img

[111 Pages Report] The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period.Growth in ELISpot and FluoroSpot Assay Market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers.

On the other hand, the availability of alternative detection technologies is expected to limit market growth during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584Diagnostic applications to hold the largest share of the ELISpot and FluoroSpot Assay Market in 2018Based on the applications, the ELISpot and FluoroSpot market is segmented into diagnostic and research applications.

In 2018, the diagnostic applications segment is expected to account for the larger share of the ELISpot and FluoroSpot market in 2018.

The large share of this segment can be attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.Hospitals and clinical laboratories are expected to be the largest end users in the ELISpot and FluoroSpot market in 2018By end user, the ELISpot and FluoroSpot market is segmented into hospitals & clinical laboratories, research institutes, and biopharmaceutical companies.

The hospitals & clinical laboratories segment is expected to account for the largest market share in 2018 while the research institutes segment is projected to grow at the highest CAGR during the forecast period.

The growing patient population and the improving healthcare infrastructure in developing countries are some of the key factors driving the growth of the hospitals & clinical laboratories segment.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=124350584Asia Pacific to grow at the highest rate during the forecast period (2018–2023)The ELISpot and FluoroSpot market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

collect
0
kriti singh 2021-08-30
img

The study involved four major activities in estimating the current size of the cell expansion market.

Exhaustive secondary research was done to collect information on the market and its different sub-segments.

The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.

After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883Major Market Growth Drivers:Growth in Cell expansion instruments market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R for cell-based therapies, and growing GMP certifications for cell therapy production facilities.Revenue Growth Analysis:[354 Pages Report] The global cell expansion market size is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.Browse and in-depth TOC on" Cell Expansion Market"595 – Tables33 – Figures354 – PagesBy product, the consumables segment accounted for the largest share of the cell expansion market in 2019.Based on the product, the cell expansion market is segmented into consumables and instruments.

The consumables segment is further segmented into reagents, media, sera, and disposables, while instruments are segmented into cell expansion supporting equipment, bioreactors, and automated cell expansion systems.

In 2019, consumables accounted for the largest share of the cell expansion products market owing to the increasing production of vaccines and other biologics in the biopharmaceutical and biotechnology industries.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883By application, the regenerative medicine and stem cell research segment accounted for the largest share of the cell expansion market in 2019.Based on application, the Cell expansion instruments market has been segmented into regenerative medicine and stem cell research, cancer & cell-based research, and others.

collect
0
kriti singh 2021-08-20
img

Major Market Growth Drivers:The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 913.3 million in 2017, at a CAGR of 13.2%.Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832Upstream Process segment dominated the Bioprocess Containers Market in 2018Based on application, the bioprocess containers market is segmented into process development, upstream processes, and downstream processes.

In 2017, the upstream process segment accounted for the largest share of the bioprocess containers market.

Upstream processes make the highest use of bioprocess containers, especially during fermentation, mixing, and culture media processing; due to this, this segment holds the largest market share.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=107645832Biopharmaceutical Companies is expected to account for the largest share for Bioprocess Containers MarketBased on end user, the bioprocess containers market is segmented into biopharmaceutical companies and life science R companies.

The biopharmaceutical companies’ segment is expected to dominate the market during the forecast period, while the life science R companies segment is expected to grow at the highest CAGR.

Biopharmaceutical manufacturing is generally characterized using single-use technologies including bioprocess containers.

Bioprocess container systems, due to their cost-effectiveness, have found wide use in biopharmaceutical manufacturing as they can lower the overall cost of production.

collect
0
kriti singh 2021-08-13
img

The research study involves four major activities to estimate the current size of the global refurbished medical equipment market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770Major Market Growth Drivers:The growth of the global refurbished medical devices market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devises, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.

However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth.

Furthermore, the growth of the market is expected to be slowed temporarily due to the COVID-19 pandemic during the forecast period.Revenue Growth Analysis:[214 Pages Report] The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025.Browse and in-depth TOC on" Refurbished Medical Equipment Market"154 – Tables23 – Figures214 – PagesThe medical imaging equipment segment accounted for the largest share of the Refurbished Medical Equipement  Market in 2019Based on product, the refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.

The medical imaging equipment segment accounted for the largest share of the market in 2019.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=770Diagnostic Imaging Centers to grow at the fastest rate in the Refurbished Medical Devices Market during the forecast period (2020-2025)Based on end users, the global Refurbished Medical Devices Market has been segmented into hospitals, ambulatory surgical centers, diagnostic imaging centers, and other end users.

collect
0
kriti singh 2021-08-10
img

The veterinary software market to grow from USD 442 million in 2017 to USD 594 million by 2022, at a CAGR of 6.1% during the forecast periodThe major factors that are expected to be driving the veterinary software market are rising companion animal ownership and demand for pet insurance with growing animal health expenditure.

However, lack of government incentives for the adoption of veterinary software, reluctance of veterinarians towards adopting new technologies, and lack of awareness about veterinary software in the developing countries are restricting the growth of Veterinary Software Industry.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186264514By delivery model, the on-premise delivery model segment is expected to dominate the veterinary software market.On the basis of delivery model, the global veterinary software market is segmented into two broad categories—on-premise model, and web-based/cloud-based model.

The on-premise model segment is estimated to account for the largest share of the global veterinary software market in 2017.

The large share of this segment can be attributed to the advantages of the on-premise delivery model, such as the low risk of data breach, flexible connection bandwidth, and the availability of easy customization options.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=186264514By practice type, the exclusive small animal practices segment is expected to register the highest CAGR during the forecast period.On the basis of practice type, the veterinary software market is segmented into exclusive small animal practices, mixed animal practice, and exclusive large animal practices.

The exclusive small animal practices segment is expected to register the highest CAGR during the forecast period.

The high growth in this segment can be attributed to the increasing number of small pet owners and rising annual spending on pet care in developed countries.The North America Veterinary Software Industry is expected to grow at the highest CAGR during the forecast periodNorth America is expected to witness the highest growth from 2017 to 2022, owing to the growing demand for quality pet care.

collect
0
kriti singh 2021-08-31
img

The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269By application, the drug discovery segment accounted for the largest share of the cell-based assays market in 2019.Based on application, the cell-based assays market is categorized into drug discovery, basic research, and other applications.

The drug discovery application segment dominated the market in 2019.

The large share of the drug discovery segment can be attributed to increasing R investments, technological innovations in supportive processes, the introduction of new drugs, and the growing number of CROs providing drug discovery services.To know about the assumptions considered for the study, Request a Sample PagesBy end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the cell-based assays market in 2019.Based on end users, the cell death assays market is segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes.

Pharmaceutical & biotechnology companies dominated the market in 2019.

The large share of this segment can be attributed to the increase in R expenditure, the growing number of drug discovery projects, and the adoption of strategic approaches such as collaborations to develop drug candidates.North America accounted for the largest share of the cell death assays market in 2019.In 2019, North America accounted for the largest share of the cell death assays market, followed by Europe.

The large share of the North American regional segment can be attributed to the availability of government and private funding for life science research, the growing penetration of CROs, comprehensive drug development regulations, and the rapid adoption of advanced technologies in the region.Key Market PlayersDanaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), AAT Bioquest (US) are the prominent players operating in the cell-based assays market.Recent DevelopmentsIn 2020, Danaher Corporation (US) launched ImageXpress Micro-confocal High-content Imaging System.In 2020, Thermo Fisher Scientific (US) acquired Phitonex, Inc. (US).

kriti singh 2021-08-30
img

The study involved four major activities to estimate the current market size for sports medicine.

Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.

Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegmentsDownload a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=751Major Market Growth Drivers: Growth in the Body Recovery Market is primarily driven by factors such the increasing incidences of sports injuries, continuous influx of new products & treatment modalities, developments in the field of regenerative medicine, rising demand for minimally invasive surgeries.Revenue Growth Analysis:The sports medicine market is expected to grow from USD 5.5 billion in 2020 to USD 7.2 billion by 2025, at a CAGR of 5.7% during the forecast period.

Browse and in-depth TOC on" Sports Medicine Market" 245 – Tables 38 – Figures 266 – Pages Body support & recovery products expected to grow at the highest rate during the forecast period On the basis of products, the Body Recovery Market is segmented into body reconstruction products (fracture & ligament repair products, arthroscopy devices, implants, prosthetics, orthobiologics), body support & recovery products (braces & support, physiotherapy equipment, and compression clothing), and accessories.

kriti singh 2021-08-24
img

The global life science instrumentation market size is projected to grow from an estimated USD 60.0 billion in 2020 to USD 79.9 billion by 2025, at a CAGR of 5.9% during the forecast period.Market growth is driven largely by factors, such as increasing expenditure on research & development by pharmaceutical & biotechnology companies, growing public & private funding for life science research, and rising incidence of target diseases & genetic disorders.

The emerging markets and increasing demand for analytical instruments are expected to present avenues of growth for market players.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38The research application segment was the largest contributor to the life science instrumentation market in 2019The research application segment accounted for the largest share of the life science instrumentation application market in 2019.

The large share of the research applications segment can be attributed to evolving global regulatory scenarios for research data publication in analytical instruments-based researches, an increasing number of research studies coupled with growing public-private funding in the field of genomic researches, and the ongoing trend of laboratory automation & integration of robotics.Next-generation sequencing (NGS) to register the highest growth over the forecast period among life science instrumentation technologiesThe Next-generation sequencing (NGS) segment is expected to register the highest growth over the forecast among the life science instrumentation technologies market over the forecast period.

The significant growth of this segment is attributed to the advantages offered by NGS technologies in DNA sequencing, which substantially provides more throughput and minimizes the need for fragment-cloning methods.

In addition, continuous technological advancements and the increasing availability of cheaper sequencing platformsRequest a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38Asia Pacific is expected to grow at the highest CAGR in the life science instrumentation market during the forecast periodThe Asia Pacific is one of the major revenue-generating regions in the life science instrumentation industry.

The strategic expansions by key market players in emerging Asian countries, the growing pharmaceutical industry in India & China, and conferences, exhibitions, & meetings on analytical instruments is driving growth in the region.Key Market PlayersAgilent Technologies (US), Becton, Dickinson, and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and Waters Corporation (US).To speak to our analyst for a discussion on the above findings, click Speak to Analyst

kriti singh 2021-08-23
img

[146 Pages Report] The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.

Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294 Consumables accounted for the largest share of the Urinalysis Systems Marketin 2019 The urine analyser market, based on product type, is segmented into consumables and instruments.

The consumables segment dominated this market in 2019.

The urinalysis consumables market is segmented into pregnancy & fertility kits, dipsticks, reagents, and disposables.

These kits have witnessed wide adoption amongst end users across the globe owing to their cost-effectiveness and ease of use.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294Increasing use of urinalysis in disease screening in 2019 Based on application, the urine analysis market is segmented into disease screening and pregnancy and fertility.

kriti singh 2021-08-19
img

The research study involved four major activities in estimating the current size of the cell & gene therapy manufacturing services market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.

After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180609441Major Market Growth Drivers:Growth in this market is primarily driven by the high incidence of cancer and other target diseases, increasing investments in pharmaceutical R, investments in advanced technologies by CDMOs, and increasing partnerships & agreements between pharmaceutical companies and CDMOs.

However, the high operational costs associated with cell & gene therapy manufacturing is expected to restrain the growth of gene therapy manufacturing services market market to a certain extent.Revenue Growth Analysis:The global cell & gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7 billion in 2021, at a CAGR of 12.4% during the forecast period.Browse and in-depth TOC on "Cell Therapy Manufacturing Services Market"348 – Tables44 – Figures299 – PagesThe cell therapy segment dominated the gene therapy manufacturing services market in 2020.On the basis of type, the cell therapy manufacturing services market is broadly segmented into cell therapy and gene therapy.

In 2020, cell therapy accounted for the largest share of the cell & gene therapy manufacturing services market.

kriti singh 2021-08-18
img

The market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global microbial identification market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects.

The size of the Microbial identification services market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10702182Major Market Growth Drivers:Growth in Microbial Identification Market is largely driven by the rising incidence of infectious diseases and the increasing frequency of pandemics, technological advancements, increasing food safety concerns, and increasing government initiatives and funding to detect and control antimicrobial-resistant species.Revenue Growth Analysis:[220 Pages Report] The global microbial identification market size is estimated to be USD 3.2 billion in 2020 and projected to reach USD 5.7 billion by 2025, at a CAGR of 12.2%.Browse and in-depth TOC on" Microbial Identification Market"261 – Tables33 – Figures220 – PagesBy the consumables segment, the panels/ID cards & media segment accounted for the largest share of the microbial identification market in 2019.On the basis of product & service type, the consumables market is segmented into panels/ID cards & media, kits and other consumables.

In 2019, panels/ID cards & media accounted for the largest share of the consumables segment.

Panels, ID cards, and media enable the easy and rapid identification of microorganisms and is a key factors driving market growthRequest a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10702182By technology, the mass spectrometry segment accounted for the largest share of the microbial identification market in 2019.On the basis of technology, the Microbial identification services market is categorized into five technology segments— mass spectrometry, PCR, flow cytometry, microscopy, and other microbial identification technologies.

The mass spectrometry segment accounted for the largest share in 2019, due to its high speed, high specificity, and applicability for a wide range of microorganisms such as bacteria, archaea, and fungi.

kriti singh 2021-08-13
img

The research study involves four major activities in estimating the current size of the biofilms treatment market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size.

After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57398610Major Market Growth Drivers:The rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries are the major factors driving the growth of Wound biofilm market.Revenue Growth Analysis:The biofilms treatment market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%.Browse and in-depth TOC on" Biofilms Treatment Market"109 – Tables33 – Figures150 – PagesTraumatic and surgical wounds segment accounted for the largest share of the biofilms treatment market in 2019.Based on the wound type, the biofilms treatment market is segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns and other open wounds.

The surgical and traumatic wounds segment accounted for the largest market share in 2019.

The large share of this segment can be attributed to the growing prevalence of diabetes and the increasing number of surgical procedures performed.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=57398610Gauzes and dressings segment to witness the highest growth rate during the forecast periodBased on product, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and lavage solutions; and grafts and matrices.

kriti singh 2021-08-11
img

[111 Pages Report] The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period.Growth in ELISpot and FluoroSpot Assay Market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers.

On the other hand, the availability of alternative detection technologies is expected to limit market growth during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584Diagnostic applications to hold the largest share of the ELISpot and FluoroSpot Assay Market in 2018Based on the applications, the ELISpot and FluoroSpot market is segmented into diagnostic and research applications.

In 2018, the diagnostic applications segment is expected to account for the larger share of the ELISpot and FluoroSpot market in 2018.

The large share of this segment can be attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.Hospitals and clinical laboratories are expected to be the largest end users in the ELISpot and FluoroSpot market in 2018By end user, the ELISpot and FluoroSpot market is segmented into hospitals & clinical laboratories, research institutes, and biopharmaceutical companies.

The hospitals & clinical laboratories segment is expected to account for the largest market share in 2018 while the research institutes segment is projected to grow at the highest CAGR during the forecast period.

The growing patient population and the improving healthcare infrastructure in developing countries are some of the key factors driving the growth of the hospitals & clinical laboratories segment.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=124350584Asia Pacific to grow at the highest rate during the forecast period (2018–2023)The ELISpot and FluoroSpot market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

kriti singh 2021-08-31
img

Growth in the fluoroscopy systems market is attributed to factors such as advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, and the growing prevalence of chronic diseases.

[187 Pages Report] The fluoroscopy equipment market is expected to grow from USD 5.9 billion in 2020 to USD 7.5 billion by 2025, at a CAGR of 4.8% during the forecast period.To know about the assumptions considered for the study, download the pdf brochure“By product, the mobile C-arms segment is expected to grow at the highest CAGR during the forecast period.”On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.

The mobile C-arms segment is projected to register the highest growth during the forecast period.

The rising prevalence of cardiovascular diseases and the increasing number of orthopedic surgeries are some of the major factors driving the growth of the mobile C-arms market.

C-arms are used for a wide range of applications, including surgeries for cardiovascular diseases, neurosurgeries, and surgeries for gastroenterology, orthopedics, traumatology, and urology disorders.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341“By application, cardiology accounted for the largest share of the diagnostic applications market in 2019”On the basis of diagnostic applications, the fluoroscopy equipment market is segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications.

Cardiology is the largest diagnostic application segment of the fluoroscopy equipment market.

kriti singh 2021-08-30
img

The study involved four major activities in estimating the current size of the cell expansion market.

Exhaustive secondary research was done to collect information on the market and its different sub-segments.

The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.

After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883Major Market Growth Drivers:Growth in Cell expansion instruments market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R for cell-based therapies, and growing GMP certifications for cell therapy production facilities.Revenue Growth Analysis:[354 Pages Report] The global cell expansion market size is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.Browse and in-depth TOC on" Cell Expansion Market"595 – Tables33 – Figures354 – PagesBy product, the consumables segment accounted for the largest share of the cell expansion market in 2019.Based on the product, the cell expansion market is segmented into consumables and instruments.

The consumables segment is further segmented into reagents, media, sera, and disposables, while instruments are segmented into cell expansion supporting equipment, bioreactors, and automated cell expansion systems.

In 2019, consumables accounted for the largest share of the cell expansion products market owing to the increasing production of vaccines and other biologics in the biopharmaceutical and biotechnology industries.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883By application, the regenerative medicine and stem cell research segment accounted for the largest share of the cell expansion market in 2019.Based on application, the Cell expansion instruments market has been segmented into regenerative medicine and stem cell research, cancer & cell-based research, and others.

kriti singh 2021-08-24
img

[183 Pages Report] The global veterinary ultrasound market size is projected to reach USD 448 million by 2025 from USD 338 million in 2020, at a CAGR of 5.8%.Factors such as growth in the companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, technological advancements are driving the growth of this market during the forecast period.

However, high cost of instruments and procedures is restraining the growth of Animal Ultrasound Market to some extent.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10482074The 2D ultrasound segment dominates the veterinary ultrasound industry, by type of ultrasound scannersBased on the type of scanners, the 2D segment accounted for the largest share of the veterinary ultrasound market in 2019.

The large share of this segment can primarily be attributed to the widespread popularity of these type of scanners in disease diagnosis as well as in pregnancy detection.By product, the cart-based segment accounted for the largest share of the market in 2019Based on product, the Animal Ultrasound Market is segmented into cart-based and portable ultrasound scanners.

In 2019, the cart-based segment accounted for the largest portion of the market due to its ease of use and is extensively used in hospitals, clinics and diagnostic centers.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10482074North America will continue to dominate the Animal Ultrasound Market during the forecast periodThe Animal Ultrasound Market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the animal/veterinary ultrasound industry in 2019.

The growth of the North American market is attributed to the increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the growing number of veterinary practices.

kriti singh 2021-08-20
img

Major Market Growth Drivers:The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 913.3 million in 2017, at a CAGR of 13.2%.Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832Upstream Process segment dominated the Bioprocess Containers Market in 2018Based on application, the bioprocess containers market is segmented into process development, upstream processes, and downstream processes.

In 2017, the upstream process segment accounted for the largest share of the bioprocess containers market.

Upstream processes make the highest use of bioprocess containers, especially during fermentation, mixing, and culture media processing; due to this, this segment holds the largest market share.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=107645832Biopharmaceutical Companies is expected to account for the largest share for Bioprocess Containers MarketBased on end user, the bioprocess containers market is segmented into biopharmaceutical companies and life science R companies.

The biopharmaceutical companies’ segment is expected to dominate the market during the forecast period, while the life science R companies segment is expected to grow at the highest CAGR.

Biopharmaceutical manufacturing is generally characterized using single-use technologies including bioprocess containers.

Bioprocess container systems, due to their cost-effectiveness, have found wide use in biopharmaceutical manufacturing as they can lower the overall cost of production.

kriti singh 2021-08-18
img

The Animal Health Market is projected to reach a value of USD 22.1 billion by 2025 from USD 15.6 billion in 2020, at a CAGR of 7.2% during the forecast period.Factors such as the rapid rise in livestock population, increasing awareness about animal health, and rising frequency of animal disease outbreaks are expected to drive the growth of the APAC animal health market.However, restrictions on the use of parasiticides in food-producing animals, shift toward vegetarian diets, and the rising cost of storage of animal vaccines are expected to restrain the growth of this market.To know about the assumptions considered for the study, Request for Free Sample ReportAPAC animal health Market DynamicsDrivers:  Rising demand of animal-derived food products According to FAO, South Asia is one of the major regions for dairy production and accounted for 20–25% of the global milk production in 2019.

In this region, India was the largest producer and consumer of milk, followed by China and Pakistan.

In 2020, the consumption of meat in India was found to be over 3.9 million metric tons; by 2030, this is expected to increase to 145.7 million metric tons.Restraints: Shift towards vegetarian dietThere is a significant rise in the prevalence of obesity and other chronic disorders.

The prevalence of obesity has increased more than twofold since 1980.

According to a journal published by Development Asia in 2018, two of five adults in the Asia Pacific region are found to be overweight or obese, and it is considered to be home to the largest absolute number of obese people, about 1 billion.To know about the assumptions considered for the study, download the PDF brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485Opportunities: Lucrative growth opportunities in India an ChinaOver the last few years, companion animal ownership has experienced steady growth, especially in emerging markets such as China and India.

Rapid urbanization and growing disposable incomes are some of the key factors driving pet ownership in these countries.

kriti singh 2021-08-13
img

The research study involves four major activities to estimate the current size of the global refurbished medical equipment market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770Major Market Growth Drivers:The growth of the global refurbished medical devices market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devises, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.

However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth.

Furthermore, the growth of the market is expected to be slowed temporarily due to the COVID-19 pandemic during the forecast period.Revenue Growth Analysis:[214 Pages Report] The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025.Browse and in-depth TOC on" Refurbished Medical Equipment Market"154 – Tables23 – Figures214 – PagesThe medical imaging equipment segment accounted for the largest share of the Refurbished Medical Equipement  Market in 2019Based on product, the refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.

The medical imaging equipment segment accounted for the largest share of the market in 2019.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=770Diagnostic Imaging Centers to grow at the fastest rate in the Refurbished Medical Devices Market during the forecast period (2020-2025)Based on end users, the global Refurbished Medical Devices Market has been segmented into hospitals, ambulatory surgical centers, diagnostic imaging centers, and other end users.

kriti singh 2021-08-12
img

[117 Pages Report] The global bone densitometers market is projected to reach USD 311 million by 2024 from USD 247 million in 2019, at a CAGR of 4.7%.The growth in the Peripheral Bone Densitometers Market is majorly driven by the increasing prevalence of osteoporosis and the rising geriatric population.

However, factors such as the high cost of bone densitometers and low awareness are expected to hinder the growth of this market.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15369222The osteoporosis & osteopenia diagnosis segment is expected to grow at the highest CAGROn the basis of application, the Bone Densitometers Market has been segmented into osteoporosis & osteopenia diagnosis, body composition measurement, rheumatoid arthritis diagnosis, cystic fibrosis diagnosis, and chronic kidney disease diagnosis.

The osteoporosis & osteopenia diagnosis segment is projected to grow at the highest CAGR during the forecast period.

This can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=15369222The hospitals & specialty clinics segment accounted for the largest share of the bone densitometers market in 2018Based on end user, the Peripheral Bone Densitometers Market is segmented into hospitals & specialty clinics, diagnostic & imaging centers, and other end users.

In 2018, hospitals & specialty clinics accounted for the largest share of the market, and this trend is expected to continue during the forecast period.

The majority of bone density scans are performed in hospitals owing to the higher preference of patients for hospital-based treatment monitoring for diseases such as cystic fibrosis, chronic kidney diseases, and osteoporosis.The Asia Pacific is expected to grow at the highest rate in the Peripheral Bone Densitometers Market in 2018The Peripheral Bone Densitome0ters Market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period.

kriti singh 2021-08-10
img

The veterinary software market to grow from USD 442 million in 2017 to USD 594 million by 2022, at a CAGR of 6.1% during the forecast periodThe major factors that are expected to be driving the veterinary software market are rising companion animal ownership and demand for pet insurance with growing animal health expenditure.

However, lack of government incentives for the adoption of veterinary software, reluctance of veterinarians towards adopting new technologies, and lack of awareness about veterinary software in the developing countries are restricting the growth of Veterinary Software Industry.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186264514By delivery model, the on-premise delivery model segment is expected to dominate the veterinary software market.On the basis of delivery model, the global veterinary software market is segmented into two broad categories—on-premise model, and web-based/cloud-based model.

The on-premise model segment is estimated to account for the largest share of the global veterinary software market in 2017.

The large share of this segment can be attributed to the advantages of the on-premise delivery model, such as the low risk of data breach, flexible connection bandwidth, and the availability of easy customization options.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=186264514By practice type, the exclusive small animal practices segment is expected to register the highest CAGR during the forecast period.On the basis of practice type, the veterinary software market is segmented into exclusive small animal practices, mixed animal practice, and exclusive large animal practices.

The exclusive small animal practices segment is expected to register the highest CAGR during the forecast period.

The high growth in this segment can be attributed to the increasing number of small pet owners and rising annual spending on pet care in developed countries.The North America Veterinary Software Industry is expected to grow at the highest CAGR during the forecast periodNorth America is expected to witness the highest growth from 2017 to 2022, owing to the growing demand for quality pet care.